CDC Panel Backs Pfizer’s Maternal RSV Vaccine

Published on September 22, 2023

Imagine being a superhero mom, passing on a shield of protection to your little one before they even enter the world! That’s what the CDC panel is recommending with Pfizer’s respiratory syncytial virus (RSV) vaccine. Just like a vaccination prepares your body to fight off harmful invaders, this vaccine helps pregnant women fend off RSV, keeping their babies safe from severe illness. RSV is like an invisible ninja that attacks the lungs, especially in vulnerable infants. By giving pregnant women this superpower, their newborns will have better defenses against RSV when they arrive. The panel members unanimously supported this superhero strategy, recognizing that protecting moms also means protecting their precious babies. This decision opens up a world of possibilities for preventing RSV in early infancy and championing maternal health along the way. To dive deeper into this exciting research and learn more about the benefits and potential side effects of Pfizer’s RSV vaccine, check out the full article!

Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Friday backed Pfizer’s respiratory syncytial virus (RSV) vaccine for women in the middle of their third trimester of pregnancy to protect their babies from severe illness. The panel members by a vote of…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>